Castle Biosciences, Inc.
Industry Group: Healthcare
Country/Region: United States of America
Identifier: NAS:CSTL
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Healthcare 180 out of 634
Universe
Global Universe 5630 out of 16006
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Fulgent Genetics, Inc. |
18.3
Low
|
106 out of 634 |
Castle Biosciences, Inc. |
21.3
Medium
|
180 out of 634 |
BML, Inc. |
22.5
Medium
|
226 out of 634 |
WELL Health Technologies Corp. |
23.2
Medium
|
254 out of 634 |
Oncoclínicas do Brasil Serviços Médicos SA |
25.2
Medium
|
297 out of 634 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Castle Biosciences, Inc.'s Exposure is Low
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Castle Biosciences, Inc.'s Management of ESG Material Risk is Average